JPS6314993B2 - - Google Patents
Info
- Publication number
- JPS6314993B2 JPS6314993B2 JP58054608A JP5460883A JPS6314993B2 JP S6314993 B2 JPS6314993 B2 JP S6314993B2 JP 58054608 A JP58054608 A JP 58054608A JP 5460883 A JP5460883 A JP 5460883A JP S6314993 B2 JPS6314993 B2 JP S6314993B2
- Authority
- JP
- Japan
- Prior art keywords
- adsorbent
- blood
- elastic body
- adsorption
- purification device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003463 adsorbent Substances 0.000 claims description 64
- 239000008280 blood Substances 0.000 claims description 40
- 210000004369 blood Anatomy 0.000 claims description 40
- 238000000746 purification Methods 0.000 claims description 17
- 238000001179 sorption measurement Methods 0.000 claims description 17
- 239000012528 membrane Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 230000003100 immobilizing effect Effects 0.000 claims description 5
- 238000004804 winding Methods 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 239000010419 fine particle Substances 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010019663 Hepatic failure Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 208000007903 liver failure Diseases 0.000 description 2
- 231100000835 liver failure Toxicity 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920000379 polypropylene carbonate Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004388 gamma ray sterilization Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Description
【発明の詳細な説明】
本発明は血液中の毒性物質を吸着除去するため
の血液浄化装置に関する。さらに詳しくは、粉末
または微粒子状の吸着剤を膜状支持体に固定化し
てなる吸着膜を使用した血液浄化装置に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a blood purification device for adsorbing and removing toxic substances in blood. More specifically, the present invention relates to a blood purification device using an adsorption membrane formed by immobilizing a powder or particulate adsorbent on a membrane support.
腎不全や肝不全の患者は血液中の毒性物質、例
えばクレアチニン、尿酸、尿素、蛋白結合物質等
を排泄する機能が低下してしまつているので血液
中に毒性物質の蓄積が起り、生命が脅かされるこ
とになる。このため透析あるいは吸着剤の使用に
より毒性物質を除去し血液の浄化を図つている。
しかしながら透析は半透膜を介した浄化法である
ため、中乃至大分子量の物質やビリルビンに代表
される蛋白結合物質の効果的な除去が一般に困難
である。これに対し、吸着剤を直接血液と接触さ
せ毒性物質を吸着除去する浄化法は、吸着剤の種
類を選択する事により血液中の種々の毒性物質を
除去する事が可能である。この場合、血液中の毒
性物質の吸着は、液相吸着により行なわれる。一
般に液相吸着では物質の拡散速度が気相に比べて
小さく、吸着速度は吸着剤の外表面積に依存する
ため、外表面積の大きな粉末あるいは微粒子状の
吸着剤の使用が望ましい。しかしながら外表面積
の大きな微粒子状の吸着剤は、そのままの状態で
は吸着剤が人体内へ流入するため使用は困難であ
る。そこで、粉末あるいは微粒子状の吸着剤によ
る血液浄化を有効に行なうためには何らかの方法
で吸着剤を固定化することが必要となる。このた
めポリマーと吸着剤を混合させ、球状あるいは膜
状に固定化する方法が提案されている。しかしな
がらその状態を良好に保つためには吸着剤量に対
するポリマーの量が多く必要となるため、吸着剤
表面のポリマーの厚みが厚くなり、それだけ吸着
力が低下する欠点を有している。又、粒状の吸着
剤を使用する場合は表面の被覆のみで良いので被
覆の厚さは薄くする事が可能であるものの、吸着
剤内部への毒性物質の移動が遅いため、大きな吸
着速度は期待できない欠点がある。 Patients with renal failure or liver failure have a decreased ability to excrete toxic substances from the blood, such as creatinine, uric acid, urea, protein-bound substances, etc., which can lead to an accumulation of toxic substances in the blood, which can be life-threatening. It will be. For this reason, attempts are made to purify the blood by removing toxic substances through dialysis or the use of adsorbents.
However, since dialysis is a purification method using a semipermeable membrane, it is generally difficult to effectively remove medium to large molecular weight substances and protein-bound substances such as bilirubin. On the other hand, purification methods in which toxic substances are adsorbed and removed by bringing an adsorbent into direct contact with blood can remove various toxic substances from blood by selecting the type of adsorbent. In this case, adsorption of toxic substances in the blood is carried out by liquid phase adsorption. Generally, in liquid phase adsorption, the diffusion rate of the substance is lower than in the gas phase, and the adsorption rate depends on the outer surface area of the adsorbent, so it is desirable to use a powder or particulate adsorbent with a large outer surface area. However, it is difficult to use a particulate adsorbent with a large external surface area because the adsorbent flows into the human body in its original state. Therefore, in order to effectively purify blood using a powder or particulate adsorbent, it is necessary to immobilize the adsorbent by some method. For this reason, a method has been proposed in which a polymer and an adsorbent are mixed and immobilized in a spherical or membrane shape. However, in order to maintain this condition in good condition, a large amount of polymer is required relative to the amount of adsorbent, which has the disadvantage that the thickness of the polymer on the surface of the adsorbent increases, and the adsorption force decreases accordingly. In addition, when using granular adsorbents, only the surface needs to be coated, so the thickness of the coating can be made thinner, but because the movement of toxic substances into the interior of the adsorbent is slow, a high adsorption rate is expected. There is a drawback that it cannot be done.
本発明者らは、粉末または微粒子状の吸着剤を
膜状支持体に固定化することにより、吸着速度の
大きな吸着体が得られることを見い出した。しか
しながら、かかる膜状吸着体を血液と接触せしめ
て、血液中の毒性物質を吸着除去する場合、吸着
体を単に血液の導出入口を有する容器に収納した
だけでは効率的な処理ができず、また吸着体端部
より吸着剤微粒子が脱離し、血液中へ移行しやす
いことがわかつた。本発明の目的は、血液中の毒
性物質を効率的に除去することができ、かつ吸着
剤微粒子の脱離しにくい血液浄化装置を提供する
ことにある。 The present inventors have discovered that an adsorbent with a high adsorption rate can be obtained by immobilizing a powder or particulate adsorbent on a membrane support. However, when such a film-like adsorbent is brought into contact with blood to adsorb and remove toxic substances from the blood, efficient treatment cannot be achieved simply by storing the adsorbent in a container with a blood inlet/outlet. It was found that adsorbent fine particles were easily detached from the end of the adsorbent and transferred into the blood. An object of the present invention is to provide a blood purification device that can efficiently remove toxic substances from blood and that makes it difficult for adsorbent particles to be detached.
すなわち本発明は、粉末または微粒子状の吸着
剤を膜状支持体に固定化してなる吸着膜をロール
状に巻いてなる吸着体、連続気泡を有する発泡体
からなり前記吸着体の両端部に密着して吸着体端
部を保護する弾性体、および剛性材料で形成され
ており前記弾性体の両側より吸着体と弾性体を全
体的に保持するとともに血液が通過し得る空間を
有する支持枠を、血液の導出入口を有する容器に
収納してなることを特徴とする血液浄化装置であ
る。以下に本発明の装置を図面に基づいて説明す
る。 That is, the present invention provides an adsorbent made of an adsorbent membrane formed by immobilizing a powder or particulate adsorbent on a membrane support and wound into a roll, and an adsorbent made of a foam having open cells that is tightly attached to both ends of the adsorbent. an elastic body that protects the end of the adsorbent, and a support frame made of a rigid material that holds the adsorbent and the elastic body as a whole from both sides of the elastic body and has a space through which blood can pass; This is a blood purification device characterized by being housed in a container having a blood inlet and outlet. The apparatus of the present invention will be explained below based on the drawings.
第1図は、本発明の血液浄化装置の一実施例に
ついての斜視図であり、収納容器を除いた部分を
分解した状態を示す。第2図は組み立てた同装置
の断面図である。図において、1は粉末または微
粒子状の吸着剤を膜状支持体に固定化した吸着膜
をロール状に巻いてなる吸着体であり、2は前記
吸着体の両端部に設けられる弾性体である。3は
吸着体と弾性体を保持するために弾性体の両側に
設けられる支持枠であり、4は前記1〜3を収納
するための容器である。 FIG. 1 is a perspective view of an embodiment of the blood purification device of the present invention, showing a disassembled state of the blood purification device excluding the storage container. FIG. 2 is a cross-sectional view of the assembled device. In the figure, 1 is an adsorbent formed by winding an adsorption membrane in which a powder or particulate adsorbent is immobilized on a membrane support, and 2 is an elastic body provided at both ends of the adsorbent. . 3 is a support frame provided on both sides of the elastic body to hold the adsorbent and the elastic body, and 4 is a container for storing the above-mentioned 1 to 3.
吸着体1に使用される吸着剤は、粉末または微
粒子状であることが必要であり、好ましい平均粒
径は10〜100μである。吸着剤が粉末または微粒
子状であることにより、大きな吸着速度が得られ
る。吸着剤としては、活性炭、有機多孔性樹脂、
多孔性アルミナ、多孔性シリカなどを例示するこ
とができる。また支持体としては、ポリエチレ
ン、ポリプロピレン、ナイロン、ポリエステル、
セルロースなどからなるフイルム、シート、織
布、不織布、メツシユ体などの膜状物を使用す
る。これらのなかでも、血液の流れを良好に保つ
うえで多孔質のものが好ましい。特に好ましい支
持体は、粒状の厚肉部と線状の薄肉部より構成さ
れた網目構造を有する多孔質フイルムまたはシー
トである。支持体の厚さは厚すぎると固定化され
る吸着剤の相対比率が減少し、薄すぎると強度が
不足するので、10〜500μの範囲が適当である。
吸着剤を支持体に固定化する方法としては、吸着
剤とポリマーとの混合溶液または融液を浸漬、塗
布、スプレーなどの方法によつて支持体上に付着
せしめ、次に乾燥、凝固、冷却などの方法により
ポリマーを固化させる方法をあげることができ
る。吸着剤を固定化したポリマーは、多孔質構造
を有していることが、高い吸着速度を得る上で好
ましい。多孔質構造を得るには公知の方法が採用
でき、例えばポリマー溶液を溶媒とは混和するが
ポリマーは溶解しない非溶媒と接触せしめること
によつて得ることができる。吸着剤を固定化する
ために使用されるポリマーとしては、ポリウレタ
ン、ポリスルホン、ポリスチレン、ポリアミド、
ポリエチレン、ポリプロピレン、ポリビニルアル
コール、親水性メタクリレート系重合体、親水性
アクリレート系重合体などをあげることができ
る。これらのなかでも血液親和性に優れたものが
好ましい。吸着剤に対するポリマーの使用量は、
吸着剤100重量部に対して20〜150重量部が適当で
あり、50〜100重量部が好ましい。上述のように
して支持体に吸着剤を固定化した吸着膜は、ロー
ル状に巻いて吸着体1とする。ロール状に巻く際
には図面に示すように心材5を使用すると便利で
ある。 The adsorbent used in the adsorbent 1 needs to be in the form of powder or fine particles, and the preferred average particle size is 10 to 100μ. When the adsorbent is in powder or particulate form, a high adsorption rate can be obtained. Adsorbents include activated carbon, organic porous resin,
Examples include porous alumina and porous silica. Supports include polyethylene, polypropylene, nylon, polyester,
Membrane materials such as films, sheets, woven fabrics, non-woven fabrics, mesh bodies, etc. made of cellulose are used. Among these, porous ones are preferred in order to maintain good blood flow. A particularly preferred support is a porous film or sheet having a network structure composed of granular thick-walled parts and linear thin-walled parts. If the thickness of the support is too thick, the relative proportion of the adsorbent immobilized will decrease, and if it is too thin, the strength will be insufficient, so a range of 10 to 500μ is appropriate.
A method for immobilizing an adsorbent on a support is to attach a mixed solution or melt of the adsorbent and polymer onto the support by dipping, coating, spraying, etc., and then drying, coagulating, and cooling. Methods such as solidifying the polymer can be mentioned. It is preferable that the polymer on which the adsorbent is immobilized has a porous structure in order to obtain a high adsorption rate. A porous structure can be obtained by a known method, for example, by bringing a polymer solution into contact with a non-solvent that is miscible with the solvent but does not dissolve the polymer. Polymers used to immobilize the adsorbent include polyurethane, polysulfone, polystyrene, polyamide,
Examples include polyethylene, polypropylene, polyvinyl alcohol, hydrophilic methacrylate polymers, and hydrophilic acrylate polymers. Among these, those with excellent blood affinity are preferred. The amount of polymer used for the adsorbent is
A suitable amount is 20 to 150 parts by weight, preferably 50 to 100 parts by weight, per 100 parts by weight of the adsorbent. The adsorption membrane with the adsorbent immobilized on the support as described above is wound into a roll to form the adsorbent 1. When winding into a roll, it is convenient to use the core material 5 as shown in the drawing.
吸着体の両端部に設けられる弾性体は、吸着体
の端部を保護するために設けるものであり、血液
の通過を阻害しない多孔質構造のものである。さ
らに具体的に言えば、ポリウレタン、シリコンな
どの高分子材料からなる連続気泡を有する発泡体
である。かかる弾性体を設けることにより、吸着
体からの吸着剤微粒子の脱離を飛躍的に減少させ
ることができ、血液浄化のために支障なく使用す
ることができるようになる。弾性体の形状は、吸
着体の端部の形状に応じて円、楕円、正方形、長
方形など適当に選ぶ。 The elastic bodies provided at both ends of the adsorbent are provided to protect the ends of the adsorbent, and have a porous structure that does not inhibit the passage of blood. More specifically, it is a foam having open cells made of a polymeric material such as polyurethane or silicone. By providing such an elastic body, detachment of adsorbent fine particles from the adsorbent can be dramatically reduced, and it can be used for blood purification without any problems. The shape of the elastic body is appropriately selected, such as a circle, an ellipse, a square, or a rectangle, depending on the shape of the end of the adsorbent.
本発明においては、上記弾性体の両側にさらに
支持枠が設けられる。支持枠は、剛性を有する材
料で形成され、第1図に示すような構造のものや
多孔質の板などのように、吸着体と弾性体を全体
的に保持できる形状であつて、血液が通過する空
間を有するものである。支持枠を設けることによ
つて弾性体を吸着体の端部全体に均一に密着させ
ることができ、弾性体の機能が十分に発揮され
る。支枠枠の材質は、ポリエチレン、ポリプロピ
レン、ポリカーボネートなどのプラスチツク材料
が有利であるが、金属、セラミツクなども使用す
ることができる。 In the present invention, support frames are further provided on both sides of the elastic body. The support frame is made of a rigid material and has a shape that can hold the adsorbent and the elastic body as a whole, such as one with the structure shown in Figure 1 or a porous plate, and has a shape that can hold the adsorbent and the elastic body as a whole. It has a space to pass through. By providing the support frame, the elastic body can be uniformly brought into close contact with the entire end portion of the adsorbent, and the function of the elastic body can be fully exhibited. As for the material of the supporting frame, plastic materials such as polyethylene, polypropylene, and polycarbonate are advantageously used, but metals, ceramics, etc. can also be used.
上述した吸着体、弾性体及び支持枠は、血液の
導出入口を有する容器に収納して血液浄化装置と
なる。収納容器は、血液の導入口6及び導出口7
が設けられている。収納容器は、ポリエチレン、
ポリプロピレン、ポリカーボネートなどの各種プ
ラスチツク材料、金属、ガラス、セラミツクなど
で形成され、必要に応じて2つまたは3つ以上の
部分から構成される。 The above-described adsorbent, elastic body, and support frame are housed in a container having a blood inlet/outlet to form a blood purification device. The storage container has a blood inlet 6 and an outlet 7.
is provided. The storage container is made of polyethylene,
It is made of various plastic materials such as polypropylene and polycarbonate, metal, glass, ceramic, etc., and is composed of two or more parts as necessary.
本発明の血液浄化装置には、さらに必要に応じ
てフイルターなどを設けることができる。また、
処理する血液は全血だけでなく、血漿あるいは血
清でもよい。また、使用に際しては滅菌するのが
好ましく、蒸気滅菌、γ線滅菌などが適当であ
る。 The blood purification device of the present invention can further be provided with a filter or the like, if necessary. Also,
The blood to be processed may be not only whole blood but also plasma or serum. Further, it is preferable to sterilize the product before use, and steam sterilization, γ-ray sterilization, etc. are suitable.
本発明の血液浄化装置は、粉末状の吸着剤を使
用しているので吸着速度が大きく、吸着体はロー
ル状に巻かれているので製造が容易である。また
ロール状に巻くことによつて微粒子の発生しやす
い吸着体端部を最小限とすることができ、しかも
該端部は弾性体により保護されているので、微粒
子の発生は非常に少なくなり、安全に血液浄化を
行うことができる。 Since the blood purification device of the present invention uses a powdered adsorbent, the adsorption speed is high, and since the adsorbent is wound into a roll, it is easy to manufacture. Furthermore, by winding it into a roll, the edges of the adsorbent where fine particles are likely to be generated can be minimized, and since the edges are protected by an elastic body, the generation of fine particles is extremely reduced. Blood purification can be performed safely.
以上詳述したように、本発明の血液浄化装置は
従来の粒状吸着剤を使用したものにくらべて吸着
速度が大きく、また微粒子の発生が少ないので、
安全で効率的に血液の浄化を行うことができ、腎
不全、肝不全、薬物中毒あるいは各種の免疫疾患
などの治療に有用である。 As detailed above, the blood purification device of the present invention has a higher adsorption rate and generates fewer fine particles than those using conventional granular adsorbents.
It can purify blood safely and efficiently, and is useful for treating renal failure, liver failure, drug addiction, and various immune diseases.
第1図は、本発明の血液浄化装置の一実施例に
おいて、収納容器を除いた部分を分解した状態を
示す斜視図である。第2図は、組立立てられた本
発明の血液浄化装置の断面図である。
1…吸着体、2…弾性体、3…支持枠、4…収
納容器、6…血液導入口、7…血液導出口。
FIG. 1 is an exploded perspective view of an embodiment of the blood purification device of the present invention, excluding a storage container. FIG. 2 is a sectional view of the assembled blood purification device of the present invention. DESCRIPTION OF SYMBOLS 1... Adsorption body, 2... Elastic body, 3... Support frame, 4... Storage container, 6... Blood inlet, 7... Blood outlet.
Claims (1)
固定化してなる吸着膜をロール状に巻いてなる吸
着体1、連続気泡を有する発泡体からなり前記吸
着体の両端部に密着して吸着体端部を保護する弾
性体2、および剛性材料で形成されており前記弾
性体の両側より吸着体と弾性体を全体的に保持す
るとともに血液が通過し得る空間を有する支持枠
3を、血液の導出入口を有する容器に収納してな
ることを特徴とする血液浄化装置。1 Adsorbent 1 is formed by winding an adsorption film formed by immobilizing a powder or particulate adsorbent onto a membrane support, and is made of a foam having open cells, and the adsorbent is tightly attached to both ends of the adsorbent for adsorption. An elastic body 2 that protects the end of the body, and a support frame 3 made of a rigid material that holds the adsorbent and the elastic body as a whole from both sides of the elastic body and has a space through which blood can pass. 1. A blood purification device, characterized in that the device is housed in a container having an inlet and an outlet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58054608A JPS59177063A (en) | 1983-03-29 | 1983-03-29 | Blood cleaning apparatus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58054608A JPS59177063A (en) | 1983-03-29 | 1983-03-29 | Blood cleaning apparatus |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59177063A JPS59177063A (en) | 1984-10-06 |
JPS6314993B2 true JPS6314993B2 (en) | 1988-04-02 |
Family
ID=12975447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58054608A Granted JPS59177063A (en) | 1983-03-29 | 1983-03-29 | Blood cleaning apparatus |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59177063A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5350286B2 (en) * | 2010-01-29 | 2013-11-27 | 日機装株式会社 | Blood purification column |
JP7022373B2 (en) | 2017-01-30 | 2022-02-18 | 東レ株式会社 | Purification column |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5332997A (en) * | 1976-09-02 | 1978-03-28 | Hoechst Ag | Membrane unit for removing poison from blood and device having same unit and method of removing poison from blood |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54127493U (en) * | 1978-02-25 | 1979-09-05 |
-
1983
- 1983-03-29 JP JP58054608A patent/JPS59177063A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5332997A (en) * | 1976-09-02 | 1978-03-28 | Hoechst Ag | Membrane unit for removing poison from blood and device having same unit and method of removing poison from blood |
Also Published As
Publication number | Publication date |
---|---|
JPS59177063A (en) | 1984-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4728432A (en) | Method for decontaminating blood | |
EP2735360B1 (en) | Adsorber device combining beads and hollow fiber membranes | |
JP6105471B2 (en) | Size selective polymer system | |
WO2003078023A1 (en) | Compound removal device | |
JP2014502971A5 (en) | ||
JP4997770B2 (en) | Adsorber | |
JP5017996B2 (en) | Leukocyte and cytokine adsorber | |
JPS6314993B2 (en) | ||
JP3353945B2 (en) | Coated carrier | |
JPS6359340B2 (en) | ||
JPH06296860A (en) | Porous support and adsorption material | |
JP2568846B2 (en) | Myoglobin adsorbent | |
JPH04348757A (en) | Method and device for treating dialyzate | |
JPS61253071A (en) | Blood purifying apparatus | |
JPS63283747A (en) | Myoglobin adsorption material | |
JPH0530442Y2 (en) | ||
JPS6361023B2 (en) | ||
JP2967205B2 (en) | Air trap with particulate filter | |
JPH0611324B2 (en) | Porous hollow fiber membrane | |
JPS6362220B2 (en) | ||
JP2568846C (en) | ||
JPS6340563A (en) | Blood purifier | |
JP2004129840A (en) | Deodorizer and deodorizing device using deodorizer | |
JPH06296864A (en) | Bradykinin adsorbent | |
Denti | Utilization of adsorbing materials for uremic blood purification |